Clinical trial
Safety and Efficacy of Lidocaine 5% Medicated Plaster in Comparison to Systemic Treatment in Postherpetic Neuralgia and Diabetic Polyneuropathic Pain.
NCT00414349 is registered in ClinicalTrials.gov with Grünenthal GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Lidocaine 5% Medicated Plaster in Comparison to Systemic Treatment in Postherpetic Neuralgia and Diabetic Polyneuropathic Pain.
- Lead sponsor
- Grünenthal GmbH
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2006
- Completion date
- March 31, 2008
- Enrollment
- 431 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
neuropathic pain